- Home
- TWIN vs RGC Comparison
TWIN vs RGC Comparison
Compare TWIN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- RGC
- Stock Information
- Founded
- TWIN 1918
- RGC 2014
- Country
- TWIN United States
- RGC Hong Kong
- Employees
- TWIN N/A
- RGC N/A
- Industry
- TWIN Industrial Machinery/Components
- RGC Medicinal Chemicals and Botanical Products
- Sector
- TWIN Industrials
- RGC Health Care
- Exchange
- TWIN Nasdaq
- RGC Nasdaq
- Market Cap
- TWIN 169.9M
- RGC 171.1M
- IPO Year
- TWIN N/A
- RGC 2021
- Fundamental
- Price
- TWIN $12.49
- RGC $6.59
- Analyst Decision
- TWIN
- RGC
- Analyst Count
- TWIN 0
- RGC 0
- Target Price
- TWIN N/A
- RGC N/A
- AVG Volume (30 Days)
- TWIN 20.7K
- RGC 26.1K
- Earning Date
- TWIN 10-31-2024
- RGC 10-25-2024
- Dividend Yield
- TWIN 1.28%
- RGC N/A
- EPS Growth
- TWIN 5.33
- RGC N/A
- EPS
- TWIN 0.79
- RGC N/A
- Revenue
- TWIN $295,127,000.00
- RGC N/A
- Revenue This Year
- TWIN N/A
- RGC N/A
- Revenue Next Year
- TWIN N/A
- RGC N/A
- P/E Ratio
- TWIN $16.05
- RGC N/A
- Revenue Growth
- TWIN 6.56
- RGC N/A
- 52 Week Low
- TWIN $10.90
- RGC $3.03
- 52 Week High
- TWIN $18.00
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- TWIN 49.15
- RGC 46.91
- Support Level
- TWIN $11.50
- RGC $5.05
- Resistance Level
- TWIN $12.84
- RGC $6.57
- Average True Range (ATR)
- TWIN 0.49
- RGC 0.83
- MACD
- TWIN 0.04
- RGC -0.16
- Stochastic Oscillator
- TWIN 56.94
- RGC 42.54
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its products portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.